Gene: KRT4
Official Full Name: keratin 4provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in differentiated layers of the mucosal and esophageal epithelia with family member KRT13. Mutations in these genes have been associated with White Sponge Nevus, characterized by oral, esophageal, and anal leukoplakia. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36892 | KRT4 Knockout cell line (A549) | Human | KRT4 | 1:3~1:4 | Negative | Online Inquiry |
KRT4 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to disrupt the expression of the keratin 4 (KRT4) gene, which encodes a type of intermediate filament protein predominantly expressed in certain epithelial tissues. These cell lines are invaluable tools for researchers investigating the role of KRT4 in various physiological and pathological processes, including skin disorders, wound healing, and the maintenance of epithelial integrity.
The key functionality of KRT4 Gene Knockout Cell Lines lies in their ability to facilitate the study of gene function through the complete ablation of KRT4 expression. This genetic modification allows for the analysis of downstream effects and compensatory mechanisms, as well as the potential pathways involved in epithelial cell differentiation and behavior. By using techniques such as CRISPR/Cas9 for precise gene editing, these cell lines provide a reliable framework for experimental consistency and reproducibility in both basic and applied biological research.
The scientific significance of KRT4 knockout models extends into translational research, where understanding KRT4's role may contribute to advances in the treatment of epithelial-related diseases, such as pachyonychia congenita and other keratinopathies. Additionally, these models can aid in drug discovery and the development of therapeutics aimed at restoring epithelial homeostasis.
KRT4 Gene Knockout Cell Lines stand out against traditional models due to their precision and the ability to create a stable knockout phenotype, avoiding the potential confounding factors associated with transient transfection methods. Furthermore, the robust characterization of these cell lines ensures that they provide reproducible and validated data for downstream applications, making them a preferred choice for forward-thinking researchers.
In conclusion, KRT4 Gene Knockout Cell Lines are an essential resource for advancing our understanding of keratin biology and its implications in health and disease. Our company brings years of expertise in genetic engineering and cell line development, ensuring that your research benefits from high-quality, scientifically validated products that meet the evolving demands of modern biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.